These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20132617)

  • 1. Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.
    Bloss E; Kuksa L; Holtz TH; Riekstina V; Skripconoka V; Kammerer S; Leimane V
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):275-81. PubMed ID: 20132617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
    Shin SS; Hyson AM; Castañeda C; Sánchez E; Alcántara F; Mitnick CD; Fawzi MC; Bayona J; Farmer PE; Kim JY; Furin JJ
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):347-53. PubMed ID: 12729340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.
    Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Yedilbayev A; Rich ML; Mukherjee JS; Furin JJ; Atwood S; Farmer PE; Keshavjee S
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1314-20. PubMed ID: 18034952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients.
    Podewils LJ; Holtz T; Riekstina V; Skripconoka V; Zarovska E; Kirvelaite G; Kreigere E; Leimane V
    Epidemiol Infect; 2011 Jan; 139(1):113-20. PubMed ID: 20429966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
    Masjedi MR; Tabarsi P; Chitsaz E; Baghaei P; Mirsaeidi M; Amiri MV; Farnia P; Javanmard P; Mansouri D; Velayati AA
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):750-5. PubMed ID: 18544199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
    Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.
    Javaid A; Khan MA; Jan F; Rauf M; Khan MA; Basit A; Mehreen S
    Tuberk Toraks; 2018 Mar; 66(1):16-25. PubMed ID: 30020037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological features of multidrug-resistant tuberculosis in a reference service in São Paulo city].
    de Melo FA; Afiune JB; Ide Neto J; de Almeida EA; Spada DT; Antelmo AN; Cruz ML
    Rev Soc Bras Med Trop; 2003; 36(1):27-34. PubMed ID: 12715060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.